Phentermine alternatives

Non-stimulant options include GLP-1 receptor agonists such as semaglutide or liraglutide that work via appetite regulation and delayed gastric emptying rather than central nervous system stimulation. These typically require weekly injections, cost more without insurance, and show higher average weight-loss percentages in studies, though they carry different side-effect profiles and supply constraints.

Teva Phentermine is a low-cost generic tablet often under $50 monthly without insurance. Compounded semaglutide can range from $200-400 monthly depending on the pharmacy and dose, offering potentially stronger results but requiring ongoing injections and lacking the same long-term safety data as FDA-approved brands.

Qsymia combines phentermine with topiramate for extended appetite control and is approved for longer-term use. Patients switching may experience steadier weight loss but must titrate carefully to manage side effects like cognitive changes or paresthesia not typical with Phentermine alone.

OTC options like orlistat or fiber-based supplements produce milder effects through fat blocking or satiety and lack the potency of prescription stimulants. They suit mild weight-loss goals and cost less but rarely match the 5-10% body-weight reduction often seen with Phentermine in short-term trials.

Tolerance can develop within weeks. Physicians may recommend cycling off, switching to a different mechanism such as GLP-1 therapy, or adding behavioral interventions rather than increasing dose, aligning with Teva's emphasis on responsible medicine access and patient safety.